SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is experiencing extreme volatility following news that its flagship NHS-Galleri cancer screening trial missed its primary endpoint, despite beating Q4 revenue and EPS estimates. While some in the community see the massive price drop as an overreaction to misunderstood trial results, others are concerned about the long-term viability and potential for further decline.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a dual announcement: a $100 million non-dilutive royalty funding agreement and a simultaneous $100 million public offering. The community is sharply divided, with many expressing frustration over perceived dilution and management's choices, while others view the moves as strategic to unlock credit, secure financial runway, and strengthen the company's negotiating position for its pipeline assets.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is trending following recent positive comments from PepsiCo regarding its distribution partnership and Alani Nu integration, alongside a J.P. Morgan price target raise. The community is actively discussing the stock's growth potential and speculating on a possible PepsiCo acquisition, amidst ongoing concerns about stock price stability and management's communication leading into upcoming financial events.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx is trending due to its recent earnings report, which highlighted strong revenue growth and significant investments for future expansion despite a net loss, coupled with a major patent extension until 2042 and the initiation of a new IBSRELA clinical trial, all fueling community speculation about a potential acquisition by Zydus Lifesciences.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending following an earnings report that showcased robust revenue growth but also a net loss driven by increased credit loss provisions and an unclear path to profitability. This has polarized the community, with many calling the significant share price drop an overreaction to underlying growth, while others condemn the BNPL model as unsustainable amidst rising credit risks.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending after its Q4 earnings surpassed analyst expectations with strong revenue, EPS, and record free cash flow. However, investor sentiment is mixed, as many express frustration over the muted stock reaction, citing concerns about lower production guidance and higher projected costs for 2026.

AIOS Foundation

AIOS is trending following its recent ticker change from NISN, prompting renewed speculation among a divided community regarding its low float and potential as a "China penny play" amidst warnings of past dilution and upcoming offerings.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems Inc. is actively trending due to significant government contract activity, with awards totaling over $65 million for the P-8A Poseidon aircraft program, alongside new commercial robotics deals, fueling community discussions around its growth trajectory and potential for substantial future contracts in the expanding Edge AI and defense sectors.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera (ATOM) is trending with significant volume as its Q4 earnings call details physical silicon results for MST in Nanosheet (GAA) architectures. This update, which hints at a potential 40% power reduction for AI chips crucial to data centers, is sparking community speculation about imminent licensing deals with major semiconductor players like TSMC and Samsung, despite ongoing concerns about its pre-revenue status.

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Guardant Health Inc

Guardant Health is trending as multiple recent FDA approvals and breakthrough designations for its liquid biopsy cancer tests, alongside strong financial results and strategic partnerships, underscore its leadership in precision oncology. The community is enthusiastically discussing its growth potential while also weighing its high valuation against increasing competition in the diagnostics space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canterbury Park Q3 Earnings Decline Y/Y as Casino Revenues Slip

CPHC's Q3 results show lower revenues and earnings amid casino softness, while development projects and food and beverage growth offer bright spots.

Canterbury Park Q2 Earnings Fall Y/Y on Lower Revenues, Higher Costs

CPHC incurs a Q2 loss as revenues drop y/y and costs rise, with casino competition and fewer race days weighing on the results despite event gains.

The Zacks Analyst Blog Highlights Apple, Advanced Micro Devices, Applied Materials, Canterbury Park and Where Food Comes From

AAPL, AMD, and AMAT lead Zacks research picks as strong growth in services, AI chips, and semis offsets broader headwinds.



Top Research Reports for Apple, AMD & Applied Materials

AAPL, AMD and AMAT lead today's top research picks, with insights on growth drivers, challenges, and shifting tech demand.

CPHC Q1 Loss Widens Y/Y on Casino Decline, Events Boost Revenues

Canterbury Park Holding Corp. engages in hosting and managing pari mutuel wagering activities. It operates through the following segments: Horse Racing, Casino, Food and Beverage, and Development. The Horse Racing segment includes simulcast and live horse racing operations. The Casino segment holds unbanked card games, poker, and table games. The Food and Beverage segment consists of concession stands, restaurant and buffet, bars, and other food venues. The Development segment owns land for racetrack operations. The company was founded by Curtis A. Sampson, Randall D. Sampson, and Dale H. Schenian on March 24, 1994 and is headquartered in Shakopee, MN.

CPHC
Canterbury Park Holding Corp

Feed

News

Sentiment

Fundamentals

Info

Latest CPHC News

CPHCCanterbury Park Holding Corp